Responding to criticism, WH plans to distribute 80 million vaccine doses worldwide by end of June

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective..